Acute murine cytomegalovirus infection:: a model for determining antiviral activity against CMV induced hepatitis

被引:8
作者
Bolger, G [1 ]
Lapeyre, N [1 ]
Rhéaume, M [1 ]
Kibler, P [1 ]
Bousquet, C [1 ]
Garneau, M [1 ]
Cordingley, M [1 ]
机构
[1] Boehringer Ingelheim Canada Ltd, Dept Biol Sci, Bio Mega Res Div, Laval, PQ H7S 2G5, Canada
关键词
mouse; cytomegalovirus; hepatitis; transaminase;
D O I
10.1016/S0166-3542(99)00063-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Acute intraperitoneal infection of weanling BALB/c mice with murine cytomegalovirus (MCMV) resulted in an inoculum titer-dependent weight loss, mortality and elevation of plasma transaminases (ALT: alanine transaminase and AST: aspartate transaminase). Three days post infection (p.i.) with 10(4.85) plaque forming units (pfu) there was 90% mortality with a mean death day p.i. of 4.1 +/- 0.2. Plasma levels of ALT and AST were elevated 24- and 15-fold, respectively. Organ titers of virus (log,, pfu/g tissue) were 6.16 in the Liver, 6.05 in the spleen, 4.0-4.7 in the lung, heart, kidney and intestine and undetectable in the muscle and brain. Organ concentrations (units/g wet-weight) of ALT were highest in the liver, whilst for AST the highest levels were found in the heart. The concentrations of ALT but not AST were reduced (35-55%) in the infected liver; the concentrations of ALT and AST were not changed in other infected organs. There were excellent correlations (r > 0.95) between viral titers in the liver, increases of plasma ALT and depletion of liver ALT. HPMPC and ganciclovir administered either p.o. or s.c. reduced mortality, increases in plasma transaminases and viral burdens in the liver and prevented depletion of liver ALT. HPMPC was similar to 10-fold more potent than ganciclovir. These results strongly suggest that intraperitoneal infection of the BALB/c mouse with MCMV represents an animal model of CMV hepatitis that can be monitored by measuring plasma ALT. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 165
页数:11
相关论文
共 37 条
[1]   3 DIFFERENT PATTERNS OF HEPATITIS-C VIRUS-INFECTION IN CHIMPANZEES [J].
ABE, K ;
INCHAUSPE, G ;
SHIKATA, T ;
PRINCE, AM .
HEPATOLOGY, 1992, 15 (04) :690-695
[2]  
ALFORD CA, 1990, VIROLOGY, P1981
[3]   RELIABILITY OF GLUTAMIC-OXALACETIC TRANSAMINASE METHODS [J].
AMADOR, E ;
MASSOD, MF ;
FRANEY, RJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1967, 47 (04) :419-+
[4]   SELECTIVE-INHIBITION OF CYTOMEGALOVIRUSES BY 9-(3'-ETHYLPHOSPHONO-1'-HYDROXYMETHYL-1'-PROPYLOXY-METHYL)GUANINE [J].
BARNARD, DL ;
HUFFMAN, JH ;
SIDWELL, RW ;
REIST, EJ .
ANTIVIRAL RESEARCH, 1993, 22 (01) :77-89
[5]   CYTOMEGALOVIRUS (CMV) IN COMPROMISED HOST(S) [J].
BETTS, RF ;
HANSHAW, JB .
ANNUAL REVIEW OF MEDICINE, 1977, 28 :103-110
[6]  
Bogin E, 1996, EUR J CLIN CHEM CLIN, V34, P625
[7]  
Collier A C, 1992, Curr Clin Top Infect Dis, V12, P309
[8]   DETECTION OF LATENT CYTOMEGALOVIRUS DNA IN DIVERSE ORGANS OF MICE [J].
COLLINS, T ;
POMEROY, C ;
JORDAN, MC .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (03) :725-729
[9]   CYTOMEGALO-VIRUS INFECTION IN PATIENTS WITH AIDS [J].
DREW, WL .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) :449-456
[10]   Severe cytomegalovirus infection in immunocompetent patients [J].
Eddleston, M ;
Peacock, S ;
Juniper, M ;
Warrell, DA .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :52-56